Generic Oncology Drug Industry in Europe and MENA

Generic Oncology Drug Industry in Europe and MENA is poised for continual growth, with projections indicating a potential rise to US$ 8.2 Billion by 2033

The generic oncology drug industry in Europe and the MENA demand region witnessed substantial revenue totaling US$ 6.5 billion in 2022, and it is projected to climb to US$ 6.7 billion by 2023. A comprehensive analysis forecasts an impressive 2.1% Compound Annual Growth Rate (CAGR) over the assessment period, indicating a surge in sales that …

Continue reading “Generic Oncology Drug Industry in Europe and MENA is poised for continual growth, with projections indicating a potential rise to US$ 8.2 Billion by 2033”

Generic Oncology Drug Industry in Europe and MENA is poised for continual growth, potentially hitting US$ 8.2 billion by 2033 | FMI

The generic oncology drug industry in Europe and the MENA size region witnessed substantial revenue totaling US$ 6.5 billion in 2022, and it is projected to climb to US$ 6.7 billion by 2023. A comprehensive analysis forecasts an impressive 2.1% Compound Annual Growth Rate (CAGR) over the assessment period, indicating a surge in sales that …

Continue reading “Generic Oncology Drug Industry in Europe and MENA is poised for continual growth, potentially hitting US$ 8.2 billion by 2033 | FMI”